Stryka-425

N/A

Report date: 2023/09/21 13:16:02
NME

Base Information

Drug NameStryka-425
Drug Alias NameStryka-425
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin stimulants
TargetsIntegrin
Therapy Area/IndicationsMuscular Dystrophy, DuchenneMuscular Dystrophies, Limb-GirdleMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Nevada RenoStrykagen Corp
China Registration ClassN/A

Develop Information

Active CompaniesStrykagen Corp
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, DuchenneMuscular Dystrophies, Limb-GirdleMuscular Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A